During the past decade, CHL - Hospital Santo Andre conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHL - Hospital Santo Andre" #1 sponsor was "Bayer" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Association for Innovation and Biomedical Research on Light and Image" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHL - Hospital Santo Andre" #1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "European Vision Institute Clinical Research Network" with 1 trials as a collaborator and "Everest Medicines" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CHL - Hospital Santo Andre" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "COVID-19" (2 trials), "Anastomotic Complication" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "CHL - Hospital Santo Andre" in a lesser frequency.

Most popular intervention types in "CHL - Hospital Santo Andre" are "Drug" (13 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Apixaban" (2 trials), "Finerenone (BAY94-8862)" (2 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHL - Hospital Santo Andre" are 17 trials for "All" genders.

Currently, there are NaN active trials in "CHL - Hospital Santo Andre". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in CHL - Hospital Santo Andre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHL - Hospital Santo Andre, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".